We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Focuses on Biomarkers, Clinical Trials in Critical Path Initiative
FDA Focuses on Biomarkers, Clinical Trials in Critical Path Initiative
March 17, 2006
The FDA unveiled its long-awaited Critical Path Opportunities List March 16, focusing on projects that will advance the use of biomarkers and streamline clinical trials.